scorecardresearch
Wednesday, September 10, 2025
TopicVaccine

Topic: Vaccine

Covid vaccine research in India at nascent stage, breakthrough unlikely this year: Experts

PTI -
At least seven research projects are currently being conducted by Indian pharma companies to develop a vaccine for coronavirus.

Early reports on CanSino’s Covid vaccine say it’s safe, generates an immune response

James Paton -
The report published by The Lancet states the vaccine stimulated production of both antibodies that can stop Covid infection along with immune T-cells.

Oxford, AstraZeneca begin advanced trials of Covid vaccine

John Lauerman -
The proposed Covid-19 vaccine is made from a weakened version of a common cold virus that’s genetically changed to make it unable to grow in humans.

Ignore hype and euphoria over any Covid vaccine news for next 2-3 months: Adar Poonawalla

Sandhya Ramesh -
At ThePrint's Off The Cuff, Serum Institute of India CEO Adar Poonawalla said efficacy and yields of production can be established only after Phase 3 trials.

Zoya Hasan says fiscal stimulus ‘too little’, Sangh & Modi united on economy says RSS

Taran Deol -
Today's political, economic & strategic punditry from Rajiv Tuli, Mekhala Krishnamurthy, S Murlidharan & Ashok Jha.

What Moderna didn’t reveal about the first Covid vaccine’s phase 1 trial

Sanjay Mishra -
Moderna’s press release on its COVID-19 mRNA vaccine trials — called mRNA-1273 — heightened hopes but missed key details.

If I had Covid-19 am I immune? This is what scientists know so far

Faye Flam -
Based on research so far, it’s reasonable to assume that most people who’ve had Covid-19 are less likely to be re-infected, and less likely to get a severe case if they do.

UK begins trial to see if Hydroxychloroquine prevents Covid-19

Neil Callanan -
The trial will enroll 40,000 healthcare workers across the world and they will be given either hydroxychloroquine or a placebo for three months.

US raises ante in race for coronavirus vaccine with pledge of $1.2 billion to AstraZeneca

John Lauerman -
President Trump is pushing his way toward the front of the line to secure a shot to protect Americans from the outbreak and allow business to resume.

Drug trial of antiviral Avignan continues in Japan despite inconclusive interim result

Lisa Du -
China will invest an estimated $1.4 trillion over six years, calling on urban govts & pvt. tech giants to roll out everything from wireless networks to artificial intelligence.
1...91011...15Page 10 of 15

On Camera

YourTurn

Opinion

Tamil Nadu politics is fracturing. Vijay entry can shake things up

R Rajagopalan -
There is an overall sense of ennui with the cynical, established and entrenched parties and politicking in the state.

China wants to lead, not create new world order, say Chinese analysts

Govt must bring pending GST reforms too

Economy

What happens to Haryana real estate agents now? Govt agency HSVP to act as broker, take commissions

Sushil Manav -
Gurugram: Stirring a storm in Haryana's real estate circles, the Haryana Shehri Vikas Pradhikaran (HSVP)—the state's urban development agency—has taken on the role of...

Defence

Denmark tweaks its banned exports list, delivery of critical system for Tejas MK 1A starts 

Snehesh Alex Philip -
HAL has produced 10 Tejas Mk 1A and is now awaiting further deliveries of engines from American firm GE—delayed by two and half years, so far.

National Interest

Punjab is fast becoming the new Northeast. And there’s a message in it for Modi

Shekhar Gupta -
In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?

Follow us

Copyright © 2025 Printline Media Pvt. Ltd. All rights reserved.